Article
Allelic imbalance of HER2 variant in sporadic breast and ovarian cancer.
Cancer genetics and cytogenetics - 1 May 2006
Puputti Marjut, Sihto Harri, Isola Jorma, Butzow Ralf, Joensuu Heikki, Nupponen Nina N
Abstract excerpt
Both breast and ovarian cancers are associated with HER2 receptor activation, which usually results from receptor overexpression and/or gene amplification. The HER-2 gene harbors a polymorphism at codon 655 (GTC/valine to ATC/isoleucine) in the transmembrane domain region, which has been associated with an elevated risk of breast cancer. The objective of this study was to determine whether the polymorphism is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
